Publications

BibTex format

@article{Gramolelli:2020:10.1158/0008-5472.CAN-19-3103,
author = {Gramolelli, S and Elbasani, E and Tuohinto, K and Nurminen, V and Guenther, T and Kallinen, RE and Kaijalainen, SP and Diaz, R and Grundhoff, A and Haglund, C and Ziegelbauer, JM and Pellinen, T and Bower, M and Francois, M and Ojala, PM},
doi = {10.1158/0008-5472.CAN-19-3103},
journal = {Cancer Research},
pages = {3116--3129},
title = {Oncogenic herpesvirus engages endothelial transcription factors SOX18 and PROX1 to increase viral genome copies and virus production},
url = {http://dx.doi.org/10.1158/0008-5472.CAN-19-3103},
volume = {80},
year = {2020}
}

Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Kaposi sarcoma is a tumor caused by Kaposi sarcoma herpesvirus (KSHV) infection and is thought to originate from lymphatic endothelial cells (LEC). While KSHV establishes latency in virtually all susceptible cell types, LECs support spontaneous expression of oncogenic lytic genes, high viral genome copies, and release of infectious virus. It remains unknown the contribution of spontaneous virus production to the expansion of KSHV-infected tumor cells and the cellular factors that render the lymphatic environment unique to KSHV life cycle. We show here that expansion of the infected cell population, observed in LECs, but not in blood endothelial cells, is dependent on the spontaneous virus production from infected LECs. The drivers of lymphatic endothelium development, SOX18 and PROX1, regulated different steps of the KSHV life cycle. SOX18 enhanced the number of intracellular viral genome copies and bound to the viral origins of replication. Genetic depletion or chemical inhibition of SOX18 caused a decrease of KSHV genome copy numbers. PROX1 interacted with ORF50, the viral initiator of lytic replication, and bound to the KSHV genome in the promoter region of ORF50, increasing its transactivation activity and KSHV spontaneous lytic gene expression and infectious virus release. In Kaposi sarcoma tumors, SOX18 and PROX1 expression correlated with latent and lytic KSHV protein expression. These results demonstrate the importance of two key transcriptional drivers of LEC fate in the regulation of the tumorigenic KSHV life cycle. Moreover, they introduce molecular targeting of SOX18 as a potential novel therapeutic avenue in Kaposi sarcoma.
AU  - Gramolelli,S
AU  - Elbasani,E
AU  - Tuohinto,K
AU  - Nurminen,V
AU  - Guenther,T
AU  - Kallinen,RE
AU  - Kaijalainen,SP
AU  - Diaz,R
AU  - Grundhoff,A
AU  - Haglund,C
AU  - Ziegelbauer,JM
AU  - Pellinen,T
AU  - Bower,M
AU  - Francois,M
AU  - Ojala,PM
DO  - 10.1158/0008-5472.CAN-19-3103
EP  - 3129
PY  - 2020///
SN  - 0008-5472
SP  - 3116
TI  - Oncogenic herpesvirus engages endothelial transcription factors SOX18 and PROX1 to increase viral genome copies and virus production
T2  - Cancer Research
UR  - http://dx.doi.org/10.1158/0008-5472.CAN-19-3103
UR  - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000558674200008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR  - https://cancerres.aacrjournals.org/content/80/15/3116
VL  - 80
ER  -

Download

ProfessorPaiviOjala

Contact

Location

Summary

Citation

BibTex format

RIS format (EndNote, RefMan)